AMGEN WINS PATENT APPEAL ON OTEZLA® (APREMILAST) ...Middle East

Appeals Court Affirms Validity of Patent Expiring in 2028 THOUSAND OAKS, Calif., April 19, 2023 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the U.S. Court of Appeals for the Federal Circuit has affirmed the judgment of the U.S. District Court for the District of New Jersey in...

Hence then, the article about amgen wins patent appeal on otezla apremilast was published today ( Wednesday 19/04/2023 - 11:48 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( AMGEN WINS PATENT APPEAL ON OTEZLA® (APREMILAST) )

Also on site :

• Merz rejects Zelensky’s ‘concrete date’ for EU membership
• Driver ‘intentionally’ rams car into synagogue in New York (VIDEO)
• Costco Is Selling a Stunningly Soft 3-Piece Quilt Set With a 'Neutral but Unique Print'